Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. (Q35054759)

6 August 2017

Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. (English)

1 reference

6 August 2017

1 reference

Fan Zhang

1

1 reference

6 August 2017

Simin Yao

2

1 reference

6 August 2017

Jing Yuan

3

1 reference

6 August 2017

Mingxia Zhang

4

1 reference

6 August 2017

Qing He

5

1 reference

6 August 2017

Guilin Yang

6

1 reference

6 August 2017

Zhiliang Gao

7

1 reference

6 August 2017

Hong Liu

8

1 reference

6 August 2017

Xinchun Chen

9

1 reference

6 August 2017

Boping Zhou

10

1 reference

6 August 2017

3 June 2011

1 reference

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

270

1 reference

Involvement of Th17 and Th1 effector responses in patients with Hepatitis B.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Emergence of the Th17 pathway and its role in host defense.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Transcriptional regulation of Th17 cell differentiation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Development, cytokine profile and function of human interleukin 17-producing helper T cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

T(H)-17 cells in the circle of immunity and autoimmunity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Expanding the effector CD4 T-cell repertoire: the Th17 lineage.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Immunology of hepatitis B virus and hepatitis C virus infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Hepatitis B virus infection--natural history and clinical consequences

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-8-270

Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

RETRACTED: Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118363

Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21639870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21639870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Coordination of interleukin-6 biology by membrane bound and soluble receptors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21639870

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1743-422X-8-270

1 reference

6 August 2017

1 reference

6 August 2017

1 reference